论文部分内容阅读
目的观察复方阿嗪米特对多西他赛和奥沙利铂引起的腹胀的治疗作用。方法符合要求的非小细胞肺癌患者60例,以多西他赛联合奥沙利铂进行化疗,其中30例给予复方阿嗪米特片,为A组,另30例为B组。对比两组病人的病例特征、腹胀程度、化疗疗效和毒性。结果复方阿嗪米特能明显减轻多西他赛和奥沙利铂引起的腹胀(P<0.05),而对多西他赛和奥沙利铂的疗效无明显影响,无进展生存期和一年期生存率均无显著区别(P均>0.05),两组病人的血液学毒性反应亦无明显区别(P>0.05)。结论复方阿嗪米特是减轻多西他赛和奥沙利铂引起的腹胀的安全有效的药物。
Objective To observe the therapeutic effect of compound azinamazole on bloating caused by docetaxel and oxaliplatin. Methods Sixty patients with non-small cell lung cancer (NSCLC) were eligible for chemotherapy with docetaxel and oxaliplatin. Thirty of them were given azimutame as group A and the other 30 as group B. The characteristics of the two groups of patients were compared, the degree of bloating, the efficacy and toxicity of chemotherapy. The results of the compound azinamide can significantly reduce docetaxel and oxaliplatin-induced abdominal distension (P <0.05), but no effect on the efficacy of docetaxel and oxaliplatin, progression-free survival and a Year survival rates were not significantly different (P> 0.05), the two groups of patients with no significant difference in hematological toxicity (P> 0.05). Conclusion Compound azinamid is a safe and effective drug to reduce the abdominal distension caused by docetaxel and oxaliplatin.